glp-1 receptor agonist structure 2 Strategies to Enhance the Therapeutic
Description
Filippatos TD, Panagiotopoulou TV, Elisaf MS
[DOI] [PubMed] [Google Scholar] 555.Liao P., Yang D., Liu D., Zheng Y
We and others have shown that GLP-1 drugs reduce risks of many substance use and addiction disorders
20 These are just a few of the many possibilities being explored as we speak
I., Brett E
